What is the evidence supporting the treatment of hypertriglyceridemia in patients with chronic kidney disease (CKD)?
Year: 2026
Type: article
Abstract: Evidence shows that combination therapies, such as statins with either ezetimibe or fenofibric acid, are effective in treating hypertriglyceridemia while being safe in patients with chronic kidney disease. Ongoing trials can further elucidate the safety and efficacy of newer agents like pemafibrate.
Author: Tripdatabase
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225743290
FWCI:
Cites:
Cited by:
Related to: